Oestrogen receptor polymorphisms and late-life depression

British Journal of Psychiatry

Volumn 199, Issue 2, 2011, Pages 126-131

  Ryan, Joanne ^a,b   Scali, Jacqueline ^a   Carrière, Isabelle ^a   Peres, Karine ^c   Rouaud, Olivier ^c   Scarabin, Pierre Yves ^d   Ritchie, Karen ^a,e   Ancelin, Marie Laure ^a,f  

^a INSERM U1061   (France)

^b Hopital Albert Chenevier   (France)

^c INSERM   (France)

^d CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

AGED; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COMMUNITY LIVING; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HORMONAL THERAPY; HUMAN; LATE LIFE DEPRESSION; MAJOR CLINICAL STUDY; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PSYCHOLOGIC TEST; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; DEPRESSIVE DISORDER, MAJOR; EFFECT MODIFIERS (EPIDEMIOLOGY); ESTROGEN REPLACEMENT THERAPY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, ESTROGEN;

EID: 79961015139     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.091751     Document Type: Article

References (33)

1. Lopez-Leon S, Janssens AC, Gonzalez-Zuloeta Ladd AM, Del-Favero J, Claes SJ, Oostra BA, et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008; 13: 772-85. (Pubitemid 352032108)
2. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999; 20: 279-307. (Pubitemid 30649809)
3. Ancelin ML, Scali J, Ritchie K. Hormonal therapy and depression: are we overlooking an important therapeutic alternative? J Psychosom Res 2007; 62: 473-85. (Pubitemid 46441264)
4. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58: 529-34. (Pubitemid 32523731)
5. Sowers MR, Jannausch ML, McConnell DS, Kardia SR, Randolph Jr JF. Endogenous estradiol and its association with estrogen receptor gene polymorphisms. Am J Med 2006; 119: S16-22. (Pubitemid 44292098)
6. Malacara JM, Perez-Luque EL, Martinez-Garza S, Sanchez-Marin FJ. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women. Maturitas 2004; 49: 163-9. (Pubitemid 39330429)
7. Corbo RM, Gambina G, Ruggeri M, Scacchi R. Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations. Dement Geriatr Cogn Disord 2006; 22: 67-72.
8. Lambert JC, Harris JM, Mann D, Lemmon H, Coates J, Cumming A, et al. Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett 2001; 306: 193-7. (Pubitemid 32530832)
9. The 3C Study Group. Vascular factors and risk of dementia: design of the three city study and baseline characteristics of the study population. Neuroepidemiology 2003; 22: 316-25.
10. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33; quiz 34-57.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
12. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1977; 1: 385-401.
13. Radloff LS, Locke BZ. The community mental health assessment survey and the CES-D scale. In Community Surveys of Psychiatric Disorders (eds MM Weissman, JK Myers, CE Ross): 177-89. Rutgers University Press, 1986.
14. Yaffe K, Lui LY, Grady D, Stone K, Morin P. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol Psychiatry 2002; 51: 677-82. (Pubitemid 34310505)
15. Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA, et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002; 105: 1879-82. (Pubitemid 34437611)
16. Rexrode KM, Ridker PM, Hegener HH, Buring JE, Manson JE, Zee RY. Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin Chem 2007; 53: 1749-56. (Pubitemid 47509667)
17. Silvestri S, Thomsen AB, Gozzini A, Bagger Y, Christiansen C, Brandi ML. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause 2006; 13: 451-61.
18. Ioannidis JP, Stavrou I, Trikalinos TA, Zois C, Brandi ML, Gennari L, et al. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res 2002; 17: 2048-60. (Pubitemid 35239206)
19. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, Axelsson CK, Gronholdt ML, Grande P, et al. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation 2007; 115: 861-71. (Pubitemid 46294727)
20. Schuit SC, de Jong FH, Stolk L, Koek WN, van Meurs JB, Schoofs MW, et al. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol 2005; 153: 327-34. (Pubitemid 41167491)
21. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-86.
22. Katz S, Ford AB, Moskowitz RW, Jaffee MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 195: 94-9.
23. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
24. Jaussent I, Dauvilliers Y, Ancelin ML, Dartigues JF, Tavernier B, Touchon J, et al. Insomnia symptoms in older adults: associated factors and gender differences. Am J Geriatr Psychiatry 2010; 19: 88-97.
25. Kravitz HM, Janssen I, Lotrich FE, Kado DM, Bromberger JT. Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife. Am J Med 2006; 119: S87-93. (Pubitemid 44292105)
26. Tiemeier H, Schuit SC, den Heijer T, van Meurs JB, van Tuijl HR, Hofman A, et al. Estrogen receptor alpha gene polymorphisms and anxiety disorder in an elderly population. Mol Psychiatry 2005; 10: 806-7. (Pubitemid 43080112)
27. Kim JJ, Pae CU, Kim MR, Min JA, Kim KH, Lee CU, et al. Association between estrogen receptor gene polymorphisms and depression in post-menopausal women: a preliminary study. Psychiatry Investig 2010; 7: 224-7.
28. Tsai SJ, Wang YC, Hong CJ, Chiu HJ. Association study of oestrogen receptor alpha gene polymorphism and suicidal behaviours in major depressive disorder. Psychiatr Genet 2003; 13: 19-22.
29. Pirskanen M, Hiltunen M, Mannermaa A, Helisalmi S, Lehtovirta M, Hanninen T, et al. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. Eur J Hum Genet 2005; 13: 1000-6. (Pubitemid 43073605)
30. Maruyama H, Toji H, Harrington CR, Sasaki K, Izumi Y, Ohnuma T, et al. Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol 2000; 57: 236-40. (Pubitemid 30097192)
31. Ryan J, Carriere I, Scali J, Ritchie K, Ancelin ML. Lifetime hormonal factors may predict late-life depression in women. Int Psychogeriatr 2008; 20: 1203-18.
32. Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 2010; 62: 155-98.
33. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001; 2: 91-9. (Pubitemid 33674000)